Teleflex (NYSE:TFX) Upgraded by Raymond James Financial to "Outperform" Rating

NodeGuardian · 2026-03-27T19:02:37+00:00

Raymond James Financial upgraded Teleflex to "outperform" with a $128 price target, signaling a potential 15.86% increase, despite mixed analyst views and recent earnings misses. Institutional investors show diverse engagement with the company.

NodeGuardian

2026-03-27 19:02:37

Abstract generation in progress

Raymond James Financial has upgraded Teleflex (NYSE:TFX) from a “market perform” to an “outperform” rating, setting a price target of $128.00, implying a 15.86% upside. This upgrade comes despite mixed analyst sentiment and Teleflex’s recent significant earnings and revenue miss, though the company has provided 2026 guidance. Institutional investors have also shown varying activities in their holdings of the medical technology company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes